Filing Flows › Medtronic (MDT) › R&D spending
Medtronic (MDT) R&D spending by quarter
Medtronic's R&D spending was $771M in Q1 FY27 (first quarter fiscal 2027), +15% from Q4 FY26. Over the last 7 quarters it ranged from $671M (Q4 FY26) to $771M (Q1 FY27).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $771M | +15% | +6% |
| Q4 FY26 | $671M | -7% | -2% |
| Q3 FY26 | $722M | -4% | +7% |
| Q2 FY26 | $754M | +4% | — |
| Q1 FY26 | $726M | +6% | — |
| Q4 FY25 | $684M | +1% | — |
| Q3 FY25 | $675M | — | — |
Q1 FY27 at a glance
Medtronic, Q1 FY27: revenue $9.8B (+14% year over year), operating margin 18.1%, net earnings $1.5B, operating cash flow $1.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is Medtronic's R&D spending?
Medtronic's R&D spending was $771M in Q1 FY27 (first quarter fiscal 2027), +15% from Q4 FY26.
How has Medtronic's R&D spending changed?
Over the last 7 quarters it ranged from $671M (Q4 FY26) to $771M (Q1 FY27).